Medicalgorithmics SA stock news
Medicalgorithmics SA has announced that its major shareholder, Biofund, is proceeding with plans to convert a previously granted loan into company shares. This decision follows the lack of a statutory quorum at the Extraordinary General Meeting (EGM) held on June 8, 2026, which prevented a vote on the proposed share capital increase. The debt--to--equity swap is expected to be a key agenda item for the upcoming Ordinary General Meeting on June 19, 2026, and is intended to strengthen the company's balance sheet while facilitating access to bank financing.